Skip to content

Comparing Letrozole and Mifepristone Before Misoprostol for First Trimester Abortion: A Randomized Trial

A Prospective Study To Compare Letrozole And Mifepristone As A Pretreatment With Misoprostol For Medical Termination In First Trimester-A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088504
Enrollment
40
Registered
2025-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Oral Letrozole Group: Oral tablet letrozole was given 10 mg once daily dose for 3 days Control Intervention1: Oral Mifepristone: Oral Mifepristone was given 200 mg single dose

Sponsors

Kajal Rani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Females 18 years and above 2. Patient requesting for medical termination of pregnancy 3. Gestational age less than equal to twelve weeks on day one of a mifepristone or Letrozole administration) as confirmed by the first trimester dating scan.

Exclusion criteria

Exclusion criteria: 1. Haemoglobin levels less than 8 g/L. 2. Presence of intrauterine contraceptive device. 3. Breastfeeding females 4. Suspected ectopic pregnancy 5. Presence of abnormal uterine lesions.

Design outcomes

Primary

MeasureTime frame
Letrozole is not inferior to Mifepristone for medical termination in the first trimester of pregnancy.Timepoint: Baseline, 3 days, 7 days, 14 days, 42 days

Secondary

MeasureTime frame
Side effects such as per vaginal bleeding were less common in patients administered letrozole compared to those who received mifepristone.Timepoint: DAy 3 , 7

Countries

India

Contacts

Public ContactHanslata Gehlot

Dr SNMC Jodhpur

pummyia@gmail.com941415070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026